Brazil at a glance
- Population
- 212.8 million 2025
- Life expectancy at birth
- 76.0 years, 2024
- People aged 65 and over
- 11.5 % of people, 2025
- Health spending per person
- 1,010 US$ per person, 2023
- Doctors
- 2.36 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
Brazil Allergy Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Allergen, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$189.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $141.3 Mn | — | — |
| 2025 (base) | $154.5 Mn | +$13.1 Mn | — |
| 2026 (forecast) | $168.8 Mn | +$14.4 Mn | +9.3% |
| 2027 (forecast) | $184.5 Mn | +$15.7 Mn | +19.5% |
| 2028 (forecast) | $201.7 Mn | +$17.2 Mn | +30.6% |
| 2029 (forecast) | $220.5 Mn | +$18.8 Mn | +42.7% |
| 2030 (forecast) | $241.0 Mn | +$20.5 Mn | +56% |
| 2031 (forecast) | $263.4 Mn | +$22.4 Mn | +70.5% |
| 2032 (forecast) | $287.9 Mn | +$24.5 Mn | +86.4% |
| 2033 (forecast) | $314.6 Mn | +$26.8 Mn | +103.7% |
| 2034 (forecast) | $343.9 Mn | +$29.3 Mn | +122.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $154.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $343.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, allergen and end user (see all) |
| Key players | Thermo Fisher Scientific Inc., Siemens Healthineers, bioMérieux SA, HYCOR Biomedical, Omega Diagnostics (see all) |
| Regulator in Brazil | ANVISASource: ANVISA. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Allergy diagnostics find what a person is allergic to, using skin prick tests and blood tests for IgE antibodies.
Key segments of the allergy Diagnostics market include test (In Vitro IgE Tests, Skin Prick Tests and Component Testing) and allergen (Food, Inhaled and Drug).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the allergy Diagnostics market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the allergy Diagnostics market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the allergy Diagnostics market.
The allergy Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class.[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.[2]
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how allergy Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.
What doctors and scientists are doing in Allergy Diagnostics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Brazil
Brazil
Brazil
Brazil
Brazil
Brazil
Digital Health · Brazil
Pharmaceuticals · Brazil
Healthcare Services · Brazil
Healthcare Services · Brazil
Pharmaceuticals · Brazil
Pharmaceuticals · Brazil